| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash, cash equivalents, and restricted cash provided by financing activities | 14,708 | 9,886 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -9,640 | -5,516 |
| Cash and cash equivalents at beginning of period | 26,332 | - |
| Cash and cash equivalents at end of period | 16,692 | - |
BIODESIX INC (BDSX)
BIODESIX INC (BDSX)